Telesis Bio
Krishna Kannan is an experienced professional in the biotechnology field with a notable career at various organizations. Currently serving as a Board Member for the International Gene Synthesis Consortium since July 2024, Krishna has held multiple senior roles at Telesis Bio from November 2019, including Senior Director of Product Development, Director of Research and Development, and Staff Scientist. Prior experience includes a position as Staff Scientist at Inscripta, Inc. and advancements at Synthetic Genomics as a Senior Scientist of Innovation. Krishna's academic background includes a Ph.D. in Pharmaceutical Biotechnology from the University of Illinois Chicago and ongoing MBA studies focused on Mergers and Acquisitions. Significant research contributions include the identification of the mechanisms of antibiotic action using innovative techniques during postdoctoral and graduate studies.
This person is not in any teams
Telesis Bio
Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.Telesis Bio was founded in 2013 and was headquartered in San Diego, USA.